Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin

Clinical and Experimental Metastasis

Volumn 18, Issue 1, 2000, Pages 45-50

  Choi, Sungki ^a   Kobayashi, Masanobu ^a   Wang, Jingxin ^a   Habelhah, Hasem ^a   Okada, Futoshi ^a   Hamada, Jun Ichi ^a   Moriuchi, Tetsuya ^a   Totsuka, Yasunori ^a   Hosokawa, Masuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ALCAM; Annexin II; Chemotherapy; Metastasis; Progression

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; COMPLEMENTARY DNA; DOXORUBICIN; LIPOCORTIN 2; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ANIMALS; ANNEXIN A2; ANTIBIOTICS, ANTINEOPLASTIC; BASE SEQUENCE; DNA PRIMERS; DOXORUBICIN; FEMALE; FIBROSARCOMA; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; OSTEOPONTIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS; TRANSFECTION;

EID: 0035139161     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026507713080     Document Type: Article

References (30)

1. The pathogenesis of cancer metastasis
2. Gene products which play a role in cancer invasion and metastasis
3. Cancer metastasis: Tumor cell and host organ properties important in metastasis to specific secondary sites
4. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells
5. Tumor invasion and metastasis-role of the extracellular matrix
6. Metastatic tumor cell interactions with endothelium, basement membrane and tissue
7. Organ-preference of metastasis. The role of endothelial cell adhesion molecules
8. Hydroxyurea and radiotherapy in head and neck cancer
9. Facilitation of tumour progression by cancer therapy
10. The incidence of metastases after multimodal therapy for cancer of the head and neck
11. Can chemotherapy enhance the malignant behaviour of tumours?
12. Regression mechanisms of mouse fibrosarcoma cells after exposure to quercetin: Diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2
13. A gene expression screen
14. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells
15. CD6-ligand interactions: A paradigm for SRCR domain function?
16. Characterization of mouse ALCAM (CD166): The CD6-binding domain is conserved in different homologs and mediates cross-species binding
17. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule)
18. Ca2+ signaling and intracellular Ca2+ binding proteins
19. Annexin II is a novel player in insulin signal transduction. Possible association between annexin II phosphorylation and insulin receptor internalization
20. Expression of annexins as a function of cellular growth state
21. Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts
22. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers
23. Expression of annexins on the cell surfaces of non-metastatic and metastatic human and rodent tumor cells
24. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma
25. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma
26. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II
27. The plasminogen activator system in pancreas cancer: Role of t-PA in the invasive potential in vitro
28. Invasion and metastasis
29. Secreted proteases. Regulation of their activity and their possible role in metastasis
30. Proteases and protease inhibitors in tumor progression